Alex Herrera discusses the response of patients with Hodgkin lymphoma on combination nivolumab/brentuximab vedotin.
Alex Herrera, MD
Advertisement
Articles by Alex Herrera, MD
Advertisement
Latest Updated Articles
Alex Herrera on Nivolumab/Brentuximab Vedotin Combination for Patients with Hodgkin LymphomaPublished: December 8th 2016 | Updated:
